Clinical trial
The Effects of Dexmedetomidine and Remifentanil on Carotid Patients
NCT00335972 · The Cleveland Clinic, Other · Terminated
Key facts
| NCT number | NCT00335972 |
|---|---|
| Title | The Effects of Dexmedetomidine and Remifentanil on Carotid Patients |
| Official title | Phase 4: The Effects of Dexmedetomidine and Remifentanil on Postoperative Hemodynamics and Pain/Opioids in Patients Undergoing Carotid Endarterectomy |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Carotid Artery Stenosis |
| Intervention type | Drug |
| Interventions | Remifentanil, Dexmedetomidine |
| Enrollment | 142 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jun 12, 2006 |
| Last update posted | Aug 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: